A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability
PHASE1CompletedINTERVENTIONAL
Enrollment
64
Participants
Timeline
Start Date
July 31, 2012
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Conditions
PharmacokineticsPharmacodynamicsHealthy SubjectsEffect of Race
Interventions
DRUG
ASP3652
Oral
Trial Locations (1)
H1 3UJ
Parexel Early Phase Clinical Unit, Harrow
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT01958047 - A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability | Biotech Hunter | Biotech Hunter